> 5678 l \pThe Free Software Foundation B=PF0*8X@"1 Helvetica1Courier1Courier New1Courier New1 Helvetica$#,##0_);($#,##0)$#,##0_);[Red]($#,##0)$#,##0.00_);($#,##0.00)$#,##0.00_);[Red]($#,##0.00)**_($* #,##0_);_($* (#,##0);_($* ""_);_(@_)*)'_(* #,##0_);_(* (#,##0);_(* ""_);_(@_)5,2_($* #,##0.00_);_($* (#,##0.00);_($* ""??_);_(@_)2+/_(* #,##0.00_);_(* (#,##0.00);_(* ""??_);_(@_)2$#,##0.00;[Red]$#,##0.003$#,##0.00;[Red]($#,##0.00)4$#,##0;[Red]($#,##00)50.00%;[Red](0.00%)60%;[Red](0%)7#,##0.00;[Red](#,##0.00)8#,##0;[Red](#,##0) + ) , * Ј ~~ ؈ ~~#؈ ~~ ؈ ~~8#܈ ~~4#܈ ~~3#܈ ~~7#܈ ~~9#܈ ~~83ffff̙̙3f3fff3f3f33333f33&#Copies of all communications in&Approximate date of commencemen&,Approximate date of commenc (1)&9CALCULATION OF REGISTRATION FEEHNO TITLE[
PROSPECTUSuhPROSPECTUS (1)4uTHE OFFERING&MARKET PRICE OF OUR COMMON SHARDILUTION&Item 14 Other Expenses of Issuaͪ
EXHIBIT INDEXEXHIBIT INDEX (1)cSignature Page Follows!Signature Page Follows (1)&NForm of Representation Date Cer
Exhibit 42TABLE OF CONTENTS,TABLE OF CONTENTS (1)FCTABLE OF CONTENTS (2)gYTABLE OF CONTENTS (3)&klYield to Maturity means the yie&vDetermination Date the number o& and each an Interest Payment %D and each an Interest Pay (1)& This conversion rate is subje&t This conversion rate is s (1)
Exhibit 433Exhibit 43 (1)7Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)PExhibit 43 (5)&k!Yield to Maturity means the (1)&+Determination Date the numb (1)&6Determination Date the numb (2)%1@ and each an Interest Pay (2)%#J and each an Interest Pay (3)SASSIGNMENT FORMz]ASSIGNMENT FORM (1)
l
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }}I"
&Zomedica Pharmaceuticals Corp.S3
12/20/2018aYCopies of all communications, including communications sent to the agent for service, to:John D. HogoboomPaul Bolger Lowenstein Sandler LLP Tingle Merrett LLP
1251 Ave of the Americas$
1250, 639  5 th Avenue S.W. New York, New York 10020 Calgary, Alberta T2P 0M9Tel: (212) 2626700Tel: (403) 5718006
Fax: (212) 2627402
Fax: (403) 5718008$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/*h@4(]Y=PF0*8X>
@
l ;$#,
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }8}$
;
&Zomedica Pharmaceuticals Corp.S3
12/20/2018kcApproximate date of commencement of proposed sale to the public: From time to time after this Regis/'If the only securities being registered ?/ 'on this Form are being offered pursuant3
+to dividend or interest reinvestment plans,'please check the following box:1
)If any of the securities being registered
x3+on this Form are to be offered on a delayed0(or continuous basis pursuant to Rule 415/'under the Securities Act of 1933, other2*than securities offered only in connection.&with dividend or interest reinvestment'plans, check the following box:4,If this Form is filed to register additional ?.&securities for an offering pursuant to4,Rule 462(b) under the Securities Act, please7/check the following box and list the Securities0(Act registration statement number of the0(earlier effective registration statementfor the same offering.2*If this Form is a posteffective amendment ?/'filed pursuant to Rule 462(c) under the/'Securities Act, check the following boxDl6*h=%xEU#H& !"#$%&'()*+,./0123456789:0 (and list the Securities Act registration1!)statement number of the earlier effective5"registration statement for the same offering.##0$(If this Form is a registration statement $?/%'pursuant to General Instruction I.D. or/&'a posteffective amendment thereto that/''shall become effective upon filing with.(&the Commission pursuant to Rule 462(e)5)under the Securities Act, check the following*box.++2,*If this Form is a posteffective amendment ,?2*to a registration statement filed pursuant5.to General Instruction I.D. filed to register3/+additional securities or additional classes30+of securities pursuant to Rule 413(b) under/1'the Securities Act, check the following2box.3354Indicate by check mark whether the registrant 4?45,is a large accelerated filer, an accelerated36+filer, a nonaccelerated filer or a smallerL7Dreporting company. See the definitions ____________________________]8Uof ?large accelerated filer,? ?accelerated Created by Morningstar Document Research.X9Pfiler? and ?smaller reporting company? http://documentresearch.morningstar.com/*:"in Rule 12b2 of the Exchange Act.:^Fl:`'v^Y=PF0*8X>
@998877
l o8
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }}8}}$
&Zomedica Pharmaceuticals Corp.S3
12/20/2018kcApproximate date of commencement of proposed sale to the public: From time to time after this Regis Large accelerated filer: ?Accelerated filer: ?
Nonaccelerated filer:7
/? (Do not check if a smaller reporting company)"
Smaller reporting company:
x Emerging growth company: x
2* If an emerging growth company, indicate x3+by check mark if the registrant has elected1)not to use the extended transition periodUMfor complying with any new or revised financial ____________________________YQaccounting standards provided pursuant Created by Morningstar Document Research.YQto Section 7(a)(2)(B) of the Securities http://documentresearch.morningstar.com/Act..)6*}M
E=PF0*8X>
@:
l G
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }*}$ }}$ }}$ }a}$ }
&Zomedica Pharmaceuticals Corp.S3
12/20/2018'CALCULATION OF REGISTRATION FEETitle of Each Class ofAmount to beProposedProposed Maximum Amount of# Securities to be Registered Registered (1) Maximum Offering Aggregate Offering Registration Fee (3)
Price per Unit
Price (3)( Common Shares, without par value~
~
~
~
+#Preferred Shares, without par value~
~
~
~
Warrants
~
~
~
~
Debt Securities~
~
~
~
Subscription Rights~
~
~
~
Units (4)~
~
~
~
TOTAL:~
G~
"8$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/2znbVqFGC=PF0*8X>
@
l *VWZ
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }$ }U}6
*
&Zomedica Pharmaceuticals Corp.S3
12/20/2018NO TITLE~
1)An indeterminate amount of the securities 4 ,of each identified class is being registered
5
as may from time to time be offered hereunder.&at indeterminate prices, along with an/'indeterminate number of securities that
0
(may be issued upon exercise, settlement,4,exchange or conversion of securities offered/'or sold hereunder. These securities may/'also be sold separately, together or as2*units with the other securities registered,$hereunder. The securities registered1)hereunder will have an aggregate offering/'price that does not exceed $300 million0(or the equivalent in any other currency,5currency unit or units, or composite currencyor currencies.~
1)Not required to be included in accordance.&with General Instruction II.D. of Form%S3 under the Securities Act.~
0(Calculated pursuant to Rule 457(o) underthe Securities Act.D lym}3Lh =PF0*8X>
@))((''
l g
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLEPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }6}
&Zomedica Pharmaceuticals Corp.S3
12/20/2018
PROSPECTUSPage ABOUT THIS PROSPECTUS~
5
CAUTIONARY NOTE ON FORWARDLOOKING STATEMENTS~
PROSPECTUS SUMMARY~
RISK FACTORS~
USE OF PROCEEDS~
$DESCRIPTION OF COMMON SHARES~
'DESCRIPTION OF PREFERRED SHARES~
DESCRIPTION OF WARRANTS~
"&DESCRIPTION OF DEBT SECURITIES~
&*"DESCRIPTION OF SUBSCRIPTION RIGHTS~
>DESCRIPTION OF UNITS~
BFORMS OF SECURITIES~
FPLAN OF DISTRIBUTION~
N0(CERTAIN U.S. AND CANADIAN FEDERAL INCOME~
RTAX CONSIDERATIONS
LEGAL MATTERS~
REXPERTS~
R+#WHERE YOU CAN FIND MORE INFORMATION~
R$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/DMlwkO ^(Ja:=PF0*8X>
@
l t
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSTHE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }6}
&Zomedica Pharmaceuticals Corp.S3
12/20/2018
PROSPECTUSPage ABOUT THIS PROSPECTUS~
f
SUMMARY~
jTHE OFFERING~
nRISK FACTORS~
r5
CAUTIONARY NOTE ON FORWARDLOOKING STATEMENTS~
zUSE OF PROCEEDS~
~)!MARKET PRICE OF OUR COMMON SHARES~
~DILUTION~
$DESCRIPTION OF COMMON SHARES~
PLAN OF DISTRIBUTION~
%MATERIAL UNITED STATES FEDERAL INCOME~
TAX CONSIDERATIONS2*CERTAIN CANADIAN INCOME TAX CONSIDERATIONS~
LEGAL MATTERS~
EXPERTS~
+#WHERE YOU CAN FIND MORE INFORMATION~
$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/@DwkO lCC%\PD=PF0*8X>
@
l 09
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }2}y<
0
&Zomedica Pharmaceuticals Corp.S3
12/20/2018THE OFFERING#Common shares offered by us2*Common shares having an aggregate offering # price of up to $50 million.
2*Common shares to be outstanding after this5Up to common shares, assuming sales of sharesoffering3+in this offering at a public offering price
8
0of $ per share, which was the closing price2*of our common shares on the NYSE American,0(on December , 2018. The actual number of0(shares issued will vary depending on the( sales price under this offering.Manner of offering1)?At the market? offering that may be made7/from time to time through our sales agent,:2Cantor Fitzgerald & Co. See ?Plan of Distribution?0(beginning on page 36 of this prospectus.Use of Proceeds3+We currently intend to use the net proceeds.&from this offering for the development.&of our product candidates, the funding6.of our working capital needs and other general1)corporate purposes. See ?Use of Proceeds?&on page 31 of this prospectus.DluiR}=ZqYE !"#$%&'()*+,./ Risk Factors/ 'Investing in our common shares involves!1!)a high degree of risk. See ?Risk Factors?"/"'beginning on page 28 of this prospectus#/#'and under similar headings in the other$/$'documents that are filed after the date%/%'hereof and incorporated by reference in&3&+this prospectus for a discussion of factors'/''to consider before deciding to purchase((our common shares.))&*NYSE American and TSXV symbol
*?ZOM?+,$____________________________1.)Created by Morningstar Document Research.0/(http://documentresearch.morningstar.com/$p,t5x5yma9=PF0*8X>
@//..
l j
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }2}}
&Zomedica Pharmaceuticals Corp.S3
12/20/2018)!MARKET PRICE OF OUR COMMON SHARES,$Fiscal Year Ending December 31, 2018High Sales PriceLow Sales Price2 *Fourth Quarter (through December 19, 2018) Q? HzG?
Third Quarter
333333@
(\?Second Quarterףp=
@?
First Quarterp=
ף@p=
ף?
+#Fiscal Year Ended December 31, 2017/'Fourth Quarter (from November 21, 2017)(\@(\?$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/.4xl`TVp
=PF0*8X>
@
l !
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }I;}
}
&Zomedica Pharmaceuticals Corp.S3
12/20/2018DILUTION( Assumed offering price per share~
9
1Net tangible book value per share as of September
Q?
30, 2018/
'Increase in net tangible book value per~
+#share attributable to new investors/'As adjusted net tangible book value per~
3+share as of September 30, 2018 after givingeffect to this offering3+Dilution per share to new investors in this~
offering$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/8ym'_0$}q =PF0*8X>
@"
l 2
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }I"}$ }
&Zomedica Pharmaceuticals Corp.S3
12/20/2018=5Item 14. Other Expenses of Issuance and Distribution.EXPENSEAMOUNT SEC Registration Fee ~
"8
Legal Fees and Expenses
*$Accounting Fees and Expenses *Trustee Fees *
Printing
*
Miscellaneous *
Total
$*$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/.dXL@4UI==PF0*8X>
@*
l AZ
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of IssuaEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }I }$ }>}$ }y
}$ }}$ }I } $ }
}$ }
A
&Zomedica Pharmaceuticals Corp.S3
12/20/2018
EXHIBIT INDEX!Incorporated By Reference Exhibit
Exhibit Title
Filed Form Exhibit
File No. Filing Date
No.
Herewith
No.?0(Sales Agreement, dated December 7, 2018, X
/'by and between Zomedica Pharmaceuticals
)
!Corp. and Cantor Fitzgerald & Co.
@0(Amalgamation Agreement by and among WiseS1333333$@
333217409
11/20/2017%Oakwood Ventures Inc., 9674128 Canada/'Inc. and ZoMedica Pharmaceuticals Inc.,dated March 30, 2016.
@<4Articles of Amalgamation of Zomedica PharmaceuticalsS1@
333217409 4/21/2017
Corp.
@5Amended and Restated ByLaw No. 1 of ZomedicaS1 @
333217409 4/21/2017Pharmaceuticals Corp.
ffffff
@1)Certificate of Amendment and RegistrationS1ffffff
@
333217409 4/21/201780of Restated Articles of Zomedica Pharmaceuticals
Corp.
333333@/'Certificate of Amalgamation of ZomedicaS1333333@
333217409 4/21/2017Pharmaceuticals Corp.Dlth(S<guL
!
"
#
$
%
&
'
(
)
*
+
,

.
/
0
1
2
3
4
5
6
7
8
9
:
;
<
=
>
?
!ffffff@!.!&Form of Certificate for Common Shares.!!!!S1!!ffffff@! !
333217409!!
11/20/2017"""""""""" "
""#@#4#,Form of Senior Debt Indenture by and between# #X##### #
##$$.$&Zomedica Pharmaceuticals Corp. and the%%%trustee.&&&&&&&&&& &
&&'333333@'.'&Form of Subordinated Debt Indenture by' 'X''''' '
''((,($and between Zomedica Pharmaceuticals)))Corp. and the trustee.********** *
**+@+0+(Form of Senior Note (included in Exhibit+ +X+++++ +
++,,
,4.2). 
.@...&Form of Subordinated Note (included in. .X..... .
..///
Exhibit 4.3).0000000000 0
001ffffff@1#1Form of Warrant Agreement.*1111111 1
112222222222 2
223@3%3Form of Warrant Certificate.*3333333 3
334444444444 4
445333333@5 5Form of Unit Agreement.*5555555 5
556666666666 6
667@7(7 Form of Subscription Agreement.*7777777 7
778888888888 8
889ffffff@9&9Opinion of Tingle Merrett LLP.9 9X99999 9
99:::::::::: :
::;<=$>____________________________1?)Created by Morningstar Document Research.Dld9P'8A)0$@
0@(http://documentresearch.morningstar.com/H=PF0*8X>
@"@@??>>
l
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXSignature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }U}$ }y<}$ }$}$
&Zomedica Pharmaceuticals Corp.S3
12/20/2018
EXHIBIT INDEX@*"Opinion of Lowenstein Sandler LLP. X
7@
0
(Consent of Independent Registered Public
X
Accounting Firm.
L7@
/
'Consent of Tingle Merrett LLP (included
X
in Exhibit 5.1).
ffffff7@3+Consent of Lowenstein Sandler LLP (included X
in Exhibit 5.2).
8@4,Power of Attorney (included on the signature X
page hereto).
9@/'Statement of Eligibility on Form T1 of
4,the Trustee for the Senior Debt Indenture.**
3333339@/'Statement of Eligibility on Form T1 of
:2the Trustee for the Subordinated Debt Indenture.**$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/BEXth<ln4e4=PF0*8X>
@
l
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }$ }}
&Zomedica Pharmaceuticals Corp.S3
12/20/2018Signature Page Follows]Very truly yours,
&
ZOMEDICA PHARMACEUTICALS CORP.
By:
"Name:?Gerald Solensky, Jr.Title:?Chairman and CEO$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/.6vj^5R=PF0*8X>
@*
l
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page Follows!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }$ }}%
&Zomedica Pharmaceuticals Corp.S3
12/20/2018Signature Page Follows]4,ACCEPTED as of the date firstabove written:
CANTOR FITZGERALD & CO.
By:Name:?Jeffrey Lumby'Title:?Senior Managing Director$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/0wvj^d=PF0*8X>
@*
l m
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }$ }}$
&Zomedica Pharmaceuticals Corp.S3
12/20/2018H@Form of Representation Date Certificate Pursuant to Section 7(l)%ZOMEDICA PHARMACEUTICALS CORP
By:
Name:Title:
$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/(TYMA5nbV.=PF0*8X>
@"
l .
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date CerTABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }$}$ }
.
&Zomedica Pharmaceuticals Corp.S3
12/20/2018Exhibit 4.2Section of the ActSection of Indenture 310(a)(1) and (2) RQ@
310(a)(3) and (4)
Inapplicable310(b)5.09(a), (b) and (d)310(c)Inapplicable
311(a)
Inapplicable311(b)Inapplicable311(c)Inapplicable312(a)ffffff@312(b)ffffff@312(c)4.02(c)313(a){Gz@ 313(b)(1){Gz@ 313(b)(2){Gz@313(c){Gz@313(d){Gz@314(a){Gz@314(b)Inapplicable314(c)(1) and (2)$@ 314(c)(3)Inapplicable314(d)Inapplicable314(e)$@314(f)Inapplicable315(a), (c) and (d)
ףp=
@D,lvj f0^.g7f !"#$%&'()*+, 315(b) q=
ףp@!315(e)!!{Gz@" 316(a)(1)""\(\@# 316(a)(2)##Not required$316(a) (last sentence)$$)\(@%316(b)%%HzG@&317(a)&&Gz@'317(b)''3.03(a) and (b)(318(a)((p=
#$@)*$+____________________________1,)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/ m4[+=PF0*8X>
@,,++
l 1j'Q,
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }I;}
1
&Zomedica Pharmaceuticals Corp.S3
12/20/2018TABLE OF CONTENTSPage Article 1 DEFINITIONS~
*
"Section 1.01 Certain Terms Defined~
Article 2 SECURITIES~
"$Section 2.01 Forms Generally~
"4
,Section 2.02 Form of Trustee?s Certification~
"of Authentication/'Section 2.03 Amount Unlimited; Issuable~
& in Series0(Section 2.04 Authentication and Delivery~
*
of Securities,$Section 2.05 Execution of Securities~
.2*Section 2.06 Certificate of Authentication~
291Section 2.07 Denomination and Date of Securities;~
2Payments of Interest/'Section 2.08 Registration, Transfer and~
2Exchange3+Section 2.09 Mutilated, Defaced, Destroyed,~
>"Lost and Stolen Securities0(Section 2.10 Cancellation of Securities;~
BDestruction Thereof)!Section 2.11 Temporary Securities~
B,$Section 2.12 Computation of Interest~
B"Section 2.13 CUSIP Numbers~
BDlpdHy3~e'x7#vW !"#$%&'()*+,./01 )Article 3 COVENANTS OF THE ISSUER AND THE~
F!TRUSTEE6".Section 3.01 Payment of Principal and Interest~
"F.#&Section 3.02 Offices for Payments, etc~
#F"$Section 3.03 Paying Agents~
$J.%&Section 3.04 Certificate of the Issuer~
%J,&$Section 3.05 List of Securityholders~
&N*'"Section 3.06 Reports by the Issuer~
'N(( Section 3.07 Corporate Existence~
(R)%Section 3.08 Restrictions on Mergers,~
)R *Sales and Consolidations'+Section 3.09 Further Assurances~
+R,$.____________________________1/)Created by Morningstar Document Research.00(http://documentresearch.morningstar.com/&@b"p4^RF=PF0*8X>
@00//..
l ;:B
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }@}$
;
&Zomedica Pharmaceuticals Corp.S3
12/20/2018TABLE OF CONTENTS=5Article 4 REMEDIES OF THE TRUSTEE AND SECURITYHOLDERS~
R ON EVENT OF DEFAULT.
&Section 4.01 Event of Default Defined;~
R3+Acceleration of Maturity; Waiver of Default/'Section 4.02 Collection of Indebtedness~
Z*
"by Trustee; Trustee May Prove Debt,$Section 4.03 Application of Proceeds~
b*"Section 4.04 Suits for Enforcement~
f91Section 4.05 Restoration of Rights on Abandonment~
fof Proceedings;3Section 4.06 Limitations on Suits by Securityholder~
f;3Section 4.07 Unconditional Right of Securityholders~
j"to Institute Certain Suits4,Section 4.08 Powers and Remedies Cumulative;~
j/'Delay or Omission Not Waiver of Default/'Section 4.09 Control by Securityholders~
j,$Section 4.10 Waiver of Past Defaults~
j7/Section 4.11 Trustee to Give Notice of Default,~
n1)But May Withhold in Certain Circumstances5Section 4.12 Right of Court to Require Filing~
n#of Undertaking to Pay Costs( Article 5 CONCERNING THE TRUSTEE~
n0(Section 5.01 Duties and Responsibilities~
nof the TrusteeDlpd>K1q+y0S !"#$%&'()*+,./0123456789:2 *Section 5.02 Certain Rights of the Trustee~
v0!(Section 5.03 Trustee Not Responsible for~
!z."&Recitals, Disposition of Securities or'#Application of Proceeds Thereof0$(Section 5.04 Trustee and Agents May Hold~
$z$%Securities; Collections, etc+&#Section 5.05 Monies Held by Trustee~
&z5'Section 5.06 Compensation and Indemnification~
'~&(of Trustee and Its Prior Claim0)(Section 5.07 Right of Trustee to Rely on~
)~"*Officers? Certificate, etc5+Section 5.08 Persons Eligible for Appointment~
+~,
as Trustee%Section 5.09 Resignation and Removal;~
~(. Appointment of Successor Trustee./&Section 5.10 Acceptance of Appointment~
/0by Successor61.Section 5.11 Merger, Conversion, Consolidation~
1,2$or Succession to Business of Trustee+3#Section 5.12 Reports to the Trustee~
304(Article 6 CONCERNING THE SECURITYHOLDERS~
405(Section 6.01 Evidence of Action Taken by~
56Securityholders7$8____________________________19)Created by Morningstar Document Research.0:(http://documentresearch.morningstar.com/:zHv/V@}5D)=PF0*8X>
@::9988
l <PX
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }=}$
<
&Zomedica Pharmaceuticals Corp.S3
12/20/2018TABLE OF CONTENTS6.Section 6.02 Proof of Execution of Instruments~
1 )and of Holding of Securities; Record Date4
,Section 6.03 Holders to be Treated as Owners~
/'Section 6.04 Securities Owned by Issuer~
Deemed Not Outstanding2
*Section 6.05 Right of Revocation of Action~
Taken)!Article 7 SUPPLEMENTAL INDENTURES~
,$Section 7.01 Supplemental Indentures~
*"Without Consent of Securityholders,$Section 7.02 Supplemental Indentures~
'With Consent of Securityholders5Section 7.03 Effect of Supplemental Indenture~
5Section 7.04 Documents to Be Given to Trustee~
.&Section 7.05 Notation on Securities in~
*"Respect of Supplemental Indentures%Article 8 CONSOLIDATION, MERGER, SALE~
OR CONVEYANCE2*Section 8.01 Issuer May Consolidate, etc.,~
on Certain Terms6.Section 8.02 Successor Corporation Substituted~
( Article 9 DISCHARGE OF INDENTURE~
/'Section 9.01 Defeasance Within One Year~
of PaymentD4lpd`>pBKA% !"#$%&'()*+,./0123456789:; Section 9.02 Defeasance~
(! Section 9.03 Covenant Defeasance~
!/"'Section 9.04 Application of Trust Money~
"(# Section 9.05 Repayment to Issuer~
#+$#Article 10 MISCELLANEOUS PROVISIONS~
$2%*Section 10.01 Incorporators, Stockholders,~
%5&Officers and Directors Exempt from Individual' Liability(%Section 10.02 Provisions of Indenture~
(;)3for the Sole Benefit of Parties and Securityholders/*'Section 10.03 Successors and Assigns of~
*!+Issuer Bound by Indenture4,,Section 10.04 Notices and Demands on Issuer,~
,#Trustee and Securityholders,.$Section 10.05 Officers? Certificates~
../&and Opinions of Counsel; Statements to0be Contained Therein01(Section 10.06 Payments Due on Saturdays,~
12Sundays and Holidays/3'Section 10.07 Conflict of Any Provision~
304(of Indenture with Trust Indenture Act of~
5N,6$Section 10.08 New York Law to Govern~
678$9____________________________1:)Created by Morningstar Document Research.0;(http://documentresearch.morningstar.com/<T`Kg!j(G;/=PF0*8X>
@;;::99
l 2fk
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }:}$
2
&Zomedica Pharmaceuticals Corp.S3
12/20/2018TABLE OF CONTENTS"Section 10.09 Counterparts~
( Section 10.10 Effect of Headings~
+
#Article 11 REDEMPTION OF SECURITIES~
.&Section 11.01 Applicability of Article~
3+Section 11.02 Notice of Redemption; Partial~
Redemptions2*Section 11.03 Payment of Securities Called~
for Redemption5Section 11.04 Exclusion of Certain Securities~
5from Eligibility for Selection for Redemption,$Section 11.05 Conversion Arrangement~
On Call For Redemption+#Article 12 CONVERSION OF SECURITIES~
.&Section 12.01 Applicability of Article~
.&Section 12.02 Right of Securityholders~
to Convert Securities3+Section 12.03 Issuance of Shares of Capital~
Stock on Conversion.&Section 12.04 No Payment or Adjustment~
!for Interest or Dividends.&Section 12.05 Adjustment of Conversion~
Rate0(Section 12.06 No Fractional Shares to Be~
IssuedDlpd0y4x?b"]8 !"#$%&'()*+,./010 (Section 12.07 Preservation of Conversion~
/!'Rights Upon Consolidation, Merger, Sale"
or Conveyance0#(Section 12.08 Notice to Security Holders~
#1$)of a Series Prior to Taking Certain Types% of Action0&(Section 12.09 Covenant to Reserve Shares~
&0'(for Issuance on Conversion of Securities2(*Section 12.10 Compliance with Governmental~
()Requirements8*0Section 12.11 Payment of Taxes Upon Certificates~
*)+!for Shares Issued Upon Conversion3,+Section 12.12 Trustee?s Duties with Respect~
, to Conversion Provisions.$/____________________________10)Created by Morningstar Document Research.01(http://documentresearch.morningstar.com/(Tr0p,X4(=PF0*8X>
@1100//
l 7v
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }$ }}}$
&Zomedica Pharmaceuticals Corp.S3
12/20/2018jbYield to Maturity means the yield to maturity on a series of securities, calculated at the time of[?],
as Trustee
By:
Authorized Signatory:
$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/*@h7+]*=PF0*8X>
@*
l
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }$ }}}$
&Zomedica Pharmaceuticals Corp.S3
12/20/2018kcDetermination Date ), the number of shares of such class of Capital Stock into which each $1,000 Pr1)ZOMEDICA PHARMACEUTICALS CORP., as Issuer
By:
Name:
Title:[ ?], as TrusteeBy:
Name:Title:$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/BX6*qAsCOuiA=PF0*8X>
@*
l
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }$ }}}$
&Zomedica Pharmaceuticals Corp.S3
12/20/2018jb[ ] and [ ] (each, an Interest Payment Date ), commencing on [ ]. Interest Record Dates: [ ] and [&ZOMEDICA PHARMACEUTICALS CORP.
By:
Name:
Title:$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/,7+}Mo=PF0*8X>
@"
l
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment ! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }$ }}$
&Zomedica Pharmaceuticals Corp.S3
12/20/2018jb[ ] and [ ] (each, an Interest Payment Date ), commencing on [ ]. Interest Record Dates: [ ] and [[ ?], as Trustee
By:
Authorized Signatory$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/*Ah7+O=PF0*8X>
@*
l
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }U5
&Zomedica Pharmaceuticals Corp.S3
12/20/2018kc[ ]. This conversion rate is subject to modification as provided in the Indenture. Such further pro1)I or we assign and transfer this Security
to1
)(Print or type name, address and zip code"of assignee or transferee)4,(Insert Social Security or other identifying)
!number of assignee or transferee)$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/*h6*t<=PF0*8X>
@
l `
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }}$ }I }U5
&Zomedica Pharmaceuticals Corp.S3
12/20/2018kc[ ]. This conversion rate is subject to modification as provided in the Indenture. Such further proDated:Signed: 4 ,(Signed exactly as name appears on the other
side of this Security)
Signature Guarantee:
%Participant in a recognized Signature%Guarantee Medallion Program (or other.&signature guarantor program reasonably"acceptable to the Trustee)$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/2`6*a_
_ =PF0*8X>
@B
l .ؽ
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }$}$ }
.
&Zomedica Pharmaceuticals Corp.S3
12/20/2018Exhibit 4.3Section of the ActSection of Indenture 310(a)(1) and (2) RQ@
310(a)(3) and (4)
Inapplicable310(b)5.09(a), (b) and (d)310(c)Inapplicable
311(a)
Inapplicable311(b)Inapplicable311(c)Inapplicable312(a)ffffff@312(b)ffffff@312(c)4.02(c)313(a){Gz@ 313(b)(1){Gz@ 313(b)(2){Gz@313(c){Gz@313(d){Gz@314(a){Gz@314(b)Inapplicable314(c)(1) and (2)$@ 314(c)(3)Inapplicable314(d)Inapplicable314(e)$@314(f)Inapplicable315(a), (c) and (d)
ףp=
@D,lvj f0^.g7f !"#$%&'()*+, 315(b) q=
ףp@!315(e)!!{Gz@" 316(a)(1)""\(\@# 316(a)(2)##Not required$316(a) (last sentence)$$)\(@%316(b)%%HzG@&317(a)&&Gz@'317(b)''3.03(a) and (b)(318(a)((p=
#$@)*$+____________________________1,)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/ m4[+=PF0*8X>
@,,++
l 5h
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }@}
5
&Zomedica Pharmaceuticals Corp.S3
12/20/2018Exhibit 4.3Page
ARTICLE 1 DEFINITIONS~
*"Section 1.01 Certain Terms Defined~
ARTICLE 2 SECURITIES~
"$
Section 2.01 Forms Generally~
"4,Section 2.02 Form of Trustee?s Certification~
"of Authentication/'Section 2.03 Amount Unlimited; Issuable~
& in Series0(Section 2.04 Authentication and Delivery~
*
of Securities,$Section 2.05 Execution of Securities~
.2*Section 2.06 Certificate of Authentication~
291Section 2.07 Denomination and Date of Securities;~
2Payments of Interest/'Section 2.08 Registration, Transfer and~
6Exchange3+Section 2.09 Mutilated, Defaced, Destroyed,~
>"Lost and Stolen Securities0(Section 2.10 Cancellation of Securities;~
BDestruction Thereof)!Section 2.11 Temporary Securities~
B,$Section 2.12 Computation of Interest~
FDlvjN6g!lSf%dE !"#$%&'()*+,./01234" Section 2.13 CUSIP Numbers~
F1!)ARTICLE 3 COVENANTS OF THE ISSUER AND THE~
!F"TRUSTEE6#.Section 3.01 Payment of Principal and Interest~
#F.$&Section 3.02 Offices for Payments, etc~
$J"%Section 3.03 Paying Agents~
%J.&&Section 3.04 Certificate of the Issuer~
&N,'$Section 3.05 List of Securityholders~
'N*("Section 3.06 Reports by the Issuer~
(N() Section 3.07 Corporate Existence~
)R*%Section 3.08 Restrictions on Mergers,~
*R +Sales and Consolidations',Section 3.09 Further Assurances~
,R=5ARTICLE 4 REMEDIES OF THE TRUSTEE AND SECURITYHOLDERS~
R.ON EVENT OF DEFAULT./&Section 4.01 Event of Default Defined;~
/R30+Acceleration of Maturity; Waiver of Default1$2____________________________13)Created by Morningstar Document Research.04(http://documentresearch.morningstar.com/.v.z<c*E9=PF0*8X>
@443322
l 7
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }=}
7
&Zomedica Pharmaceuticals Corp.S3
12/20/2018Exhibit 4.3Page /
'Section 4.02 Collection of Indebtedness~
Z*"by Trustee; Trustee May Prove Debt,$Section 4.03 Application of Proceeds~
b*
"Section 4.04 Suits for Enforcement~
f91Section 4.05 Restoration of Rights on Abandonment~
fof Proceedings;3Section 4.06 Limitations on Suits by Securityholder~
j;3Section 4.07 Unconditional Right of Securityholders~
j"to Institute Certain Suits4,Section 4.08 Powers and Remedies Cumulative;~
j/'Delay or Omission Not Waiver of Default/'Section 4.09 Control by Securityholders~
n,$Section 4.10 Waiver of Past Defaults~
n7/Section 4.11 Trustee to Give Notice of Default,~
n1)But May Withhold in Certain Circumstances5Section 4.12 Right of Court to Require Filing~
r#of Undertaking to Pay Costs( ARTICLE 5 CONCERNING THE TRUSTEE~
r0(Section 5.01 Duties and Responsibilities~
rof the Trustee2*Section 5.02 Certain Rights of the Trustee~
v0(Section 5.03 Trustee Not Responsible for~
~DXlvjN6MN(n0kD
!"#$%&'()*+,./0123456. &Recitals, Disposition of Securities or'!Application of Proceeds Thereof0"(Section 5.04 Trustee and Agents May Hold~
"~$#Securities; Collections, etc+$#Section 5.05 Monies Held by Trustee~
$~5%Section 5.06 Compensation and Indemnification~
%~&&of Trustee and Its Prior Claim0'(Section 5.07 Right of Trustee to Rely on~
'"(Officers? Certificate, etc5)Section 5.08 Persons Eligible for Appointment~
)*
as Trustee+%Section 5.09 Resignation and Removal;~
+(, Appointment of Successor Trustee.&Section 5.10 Acceptance of Appointment~
.by Successor6/.Section 5.11 Merger, Conversion, Consolidation~
/,0$or Succession to Business of Trustee+1#Section 5.12 Reports to the Trustee~
123$4____________________________15)Created by Morningstar Document Research.06(http://documentresearch.morningstar.com/2'a9I#[NB6=PF0*8X>
@665544
l 6
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }=}
6
&Zomedica Pharmaceuticals Corp.S3
12/20/2018Exhibit 4.3Page 0
(ARTICLE 6 CONCERNING THE SECURITYHOLDERS~
0(Section 6.01 Evidence of Action Taken by~
Securityholders6
.Section 6.02 Proof of Execution of Instruments~
1)and of Holding of Securities; Record Date4,Section 6.03 Holders to be Treated as Owners~
/'Section 6.04 Securities Owned by Issuer~
Deemed Not Outstanding2*Section 6.05 Right of Revocation of Action~
Taken)!ARTICLE 7 SUPPLEMENTAL INDENTURES~
,$Section 7.01 Supplemental Indentures~
*"Without Consent of Securityholders,$Section 7.02 Supplemental Indentures~
'With Consent of Securityholders5Section 7.03 Effect of Supplemental Indenture~
5Section 7.04 Documents to Be Given to Trustee~
.&Section 7.05 Notation on Securities in~
*"Respect of Supplemental Indentures%ARTICLE 8 CONSOLIDATION, MERGER, SALE~
OR CONVEYANCE0(Section 8.01 Issuer May Consolidate, etc~
D
lvjN6Oqu7~> !"#$%&'()*+,./0123456 .Section 8.02 Successor Corporation Substituted~
(! ARTICLE 9 DISCHARGE OF INDENTURE~
!/"'Section 9.01 Defeasance Within One Year~
"#
of Payment$Section 9.02 Defeasance~
$(% Section 9.03 Covenant Defeasance~
%/&'Section 9.04 Application of Trust Money~
&(' Section 9.05 Repayment to Issuer~
'+(#ARTICLE 10 MISCELLANEOUS PROVISIONS~
(2)*Section 10.01 Incorporators, Stockholders,~
)5*Officers and Directors Exempt from Individual+ Liability,%Section 10.02 Provisions of Indenture~
,;3for the Sole Benefit of Parties and Securityholders/.'Section 10.03 Successors and Assigns of~
.!/Issuer Bound by Indenture40,Section 10.04 Notices and Demands on Issuer,~
0#1Trustee and Securityholders2$3____________________________14)Created by Morningstar Document Research.05(http://documentresearch.morningstar.com/04~='{Ar3H!=PF0*8X>
@554433
l @
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }:}
@
&Zomedica Pharmaceuticals Corp.S3
12/20/2018Exhibit 4.3Page ,
$Section 10.05 Officers? Certificates~
.&and Opinions of Counsel; Statements tobe Contained Therein0
(Section 10.06 Payments Due on Saturdays,~
Sundays and Holidays/'Section 10.07 Conflict of Any Provision~
0(of Indenture with Trust Indenture Act of~
N,$Section 10.08 New York Law to Govern~
"Section 10.09 Counterparts~
( Section 10.10 Effect of Headings~
+#ARTICLE 11 REDEMPTION OF SECURITIES~
.&Section 11.01 Applicability of Article~
3+Section 11.02 Notice of Redemption; Partial~
Redemptions2*Section 11.03 Payment of Securities Called~
for Redemption5Section 11.04 Exclusion of Certain Securities~
5from Eligibility for Selection for Redemption,$Section 11.05 Conversion Arrangement~
On Call For Redemption+#ARTICLE 12 CONVERSION OF SECURITIES~
DlvjN6dDOS<^ !"#$%&'()*+,./0123456789:;<=>?. &Section 12.01 Applicability of Article~
.!&Section 12.02 Right of Securityholders~
!"to Convert Securities3#+Section 12.03 Issuance of Shares of Capital~
#$Stock on Conversion.%&Section 12.04 No Payment or Adjustment~
%!&for Interest or Dividends.'&Section 12.05 Adjustment of Conversion~
'(Rate0)(Section 12.06 No Fractional Shares to Be~
)*Issued0+(Section 12.07 Preservation of Conversion~
+/,'Rights Upon Consolidation, Merger, Sale
or Conveyance0.(Section 12.08 Notice to Security Holders~
.1/)of a Series Prior to Taking Certain Types0 of Action01(Section 12.09 Covenant to Reserve Shares~
102(for Issuance on Conversion of Securities23*Section 12.10 Compliance with Governmental~
34Requirements850Section 12.11 Payment of Taxes Upon Certificates~
5)6!for Shares Issued Upon Conversion37+Section 12.12 Trustee?s Duties with Respect~
7 8to Conversion Provisions.9&ARTICLE 13 SUBORDINATION OF SECURITIES~
90:(Section 13.01 Agreement Of Subordination~
:;<$=____________________________1>)Created by Morningstar Document Research.0?(http://documentresearch.morningstar.com/Dl_VF}d"bJ&d=PF0*8X>
@??>>==
l
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }U5}
&Zomedica Pharmaceuticals Corp.S3
12/20/2018Exhibit 4.3Page )
!Section 13.02 Payments to Holders~
/'Section 13.03 Subrogation Of Securities~
.&Section 13.04 Authorization By Holders~
'
Section 13.05 Notice to Trustee~
2*Section 13.06 Trustee?s Relation to Senior~
Indebtedness4,Section 13.07 No Impairment Of Subordination~
'Section 13.08 Rights Of Trustee~
$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/2vjN6zAfZN&=PF0*8X>
@
l 8+
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }$ }}}$
&Zomedica Pharmaceuticals Corp.S3
12/20/2018jbYield to Maturity means the yield to maturity on a series of securities, calculated at the time of
[ ?],
as Trustee
By:
Authorized Signatory:
$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/*Ah7+\)=PF0*8X>
@*
l u5
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }}}$
&Zomedica Pharmaceuticals Corp.S3
12/20/2018kcDetermination Date ), the number of shares of such class of Capital Stock into which each $1,000 Pr1 )ZOMEDICA PHARMACEUTICALS CORP., as Issuer
By:
Name:
Title:$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/,*6*b9=PF0*8X>
@"
l ?
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }}}$
&Zomedica Pharmaceuticals Corp.S3
12/20/2018kcDetermination Date ), the number of shares of such class of Capital Stock into which each $1,000 Pr [ ?] , as Trustee
By:
Name:
Title:$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/,6*nE=PF0*8X>
@"
l I
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (3)ASSIGNMENT FORMASSIGNMENT FORM (1)U }}}$
&Zomedica Pharmaceuticals Corp.S3
12/20/2018jb[ ] and [ ] (each, an Interest Payment Date ), commencing on [ ]. Interest Record Dates: [ ] and [&ZOMEDICA PHARMACEUTICALS CORP.
By:
Name:
Title:
$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/*h7+i?3'=PF0*8X>
@"
l VS
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2)ASSIGNMENT FORMASSIGNMENT FORM (1)U }}}$
&Zomedica Pharmaceuticals Corp.S3
12/20/2018jb[ ] and [ ] (each, an Interest Payment Date ), commencing on [ ]. Interest Record Dates: [ ] and [[ ?] , as Trustee
By:Authorized Signatory
$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/(T7+[OC=PF0*8X>
@"
l ]
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORM (1)U }U5
&Zomedica Pharmaceuticals Corp.S3
12/20/2018ASSIGNMENT FORM1)I or we assign and transfer this Security
to1
)(Print or type name, address and zip code"of assignee or transferee)4,(Insert Social Security or other identifying)
!number of assignee or transferee)$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/*h~rf1#cWK#=PF0*8X>
@
l h
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??'!Copies of all communications in!Approximate date of commencemen!Approximate date of commenc (1)!CALCULATION OF REGISTRATION FEE
NO TITLE
PROSPECTUSPROSPECTUS (1)THE OFFERING!MARKET PRICE OF OUR COMMON SHAR
DILUTION!Item 14 Other Expenses of Issua
EXHIBIT INDEXEXHIBIT INDEX (1)Signature Page FollowsSignature Page Follows (1)!Form of Representation Date Cer
Exhibit 42TABLE OF CONTENTSTABLE OF CONTENTS (1)TABLE OF CONTENTS (2)TABLE OF CONTENTS (3)!Yield to Maturity means the yie!Determination Date the number o! and each an Interest Payment and each an Interest Pay (1)! This conversion rate is subje! This conversion rate is s (1)
Exhibit 43Exhibit 43 (1)Exhibit 43 (2)Exhibit 43 (3)Exhibit 43 (4)Exhibit 43 (5)!Yield to Maturity means the (1)!Determination Date the numb (1)!Determination Date the numb (2) and each an Interest Pay (2) and each an Interest Pay (3)ASSIGNMENT FORMU }}$ }I }U5
&Zomedica Pharmaceuticals Corp.S3
12/20/2018ASSIGNMENT FORMDated:Signed: 4 ,(Signed exactly as name appears on the other
side of this Security)Signature Guarantee:

%Participant in a recognized Signature%Guarantee Medallion Program (or other.&signature guarantor program reasonably"acceptable to the Trustee)$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/0~rfc'Ee=PF0*8X>
@B
Root Entry FBook
i
!"#$%&'()*+,./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{}~
!"#$%&'()*+,./01234